492 related articles for article (PubMed ID: 20964615)
1. Favorable maternal and fetal effects of danshensu in an experimental mice model of preeclampsia.
Shen Y; Hu Y; Zhang Y
Hypertens Pregnancy; 2011; 30(4):465-80. PubMed ID: 20964615
[TBL] [Abstract][Full Text] [Related]
2. Effects of Danshensu on maternal syndrome in phosphatidylserine/phosphatidylcholine microvesicle induced-mouse model: is it a candidate for preeclampsia remedy?
Shen Y; Hu YL; Zhang Y; Wang JM
Chin Med J (Engl); 2010 Apr; 123(7):895-900. PubMed ID: 20497684
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of anticoagulant agents on preeclampsia in a murine model induced by phosphatidylserine/phosphatidylcholine microvesicles.
Zhang Y; Hua Z; Zhang K; Meng K; Hu Y
Placenta; 2009 Dec; 30(12):1065-70. PubMed ID: 19837457
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylserine/phosphatidylcholine microvesicles can induce preeclampsia-like changes in pregnant mice.
Omatsu K; Kobayashi T; Murakami Y; Suzuki M; Ohashi R; Sugimura M; Kanayama N
Semin Thromb Hemost; 2005 Jun; 31(3):314-20. PubMed ID: 16052403
[TBL] [Abstract][Full Text] [Related]
5. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
Groom KM; David AL
Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
[TBL] [Abstract][Full Text] [Related]
6. Effects of preeclampsia-like symptoms at early gestational stage on feto-placental outcomes in a mouse model.
Ma RQ; Sun MN; Yang Z
Chin Med J (Engl); 2010 Mar; 123(6):707-12. PubMed ID: 20368091
[TBL] [Abstract][Full Text] [Related]
7. Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.
Kupferminc MJ; Kliger C; Rimon E; Asher-Landsberg J; Skornick-Rapaport A; Gamzu R; Yogev Y
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8055-8061. PubMed ID: 34154497
[TBL] [Abstract][Full Text] [Related]
8. Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease.
North RA; Ferrier C; Gamble G; Fairley KF; Kincaid-Smith P
Aust N Z J Obstet Gynaecol; 1995 Nov; 35(4):357-62. PubMed ID: 8717553
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis.
Cruz-Lemini M; Vázquez JC; Ullmo J; Llurba E
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1126-S1144.e17. PubMed ID: 34301348
[TBL] [Abstract][Full Text] [Related]
10. Tadalafil Improves L-NG-Nitroarginine Methyl Ester-Induced Preeclampsia With Fetal Growth Restriction-Like Symptoms in Pregnant Mice.
Yoshikawa K; Umekawa T; Maki S; Kubo M; Nii M; Tanaka K; Tanaka H; Osato K; Kamimoto Y; Kondo E; Ikemura K; Okuda M; Katayama K; Miyoshi T; Hosoda H; Ma N; Yoshida T; Ikeda T
Am J Hypertens; 2017 Dec; 31(1):89-96. PubMed ID: 28992178
[TBL] [Abstract][Full Text] [Related]
11. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
[TBL] [Abstract][Full Text] [Related]
12. Prevention of fetal death in the antiphospholipid antibody syndrome.
Cowchock S
Lupus; 1996 Oct; 5(5):467-72. PubMed ID: 8902784
[TBL] [Abstract][Full Text] [Related]
13. Thrombomodulin improves maternal and fetal conditions in an experimental pre-eclampsia rat model.
Shin M; Hino H; Tamura M; Ishizuka B; Tanaka M; Suzuki N; Tateda T
J Obstet Gynaecol Res; 2014 May; 40(5):1226-34. PubMed ID: 24689942
[TBL] [Abstract][Full Text] [Related]
14. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
Erez O; Gotsch F; Mazaki-Tovi S; Vaisbuch E; Kusanovic JP; Kim CJ; Chaiworapongsa T; Hoppensteadt D; Fareed J; Than NG; Nhan-Chang CL; Yeo L; Pacora P; Mazor M; Hassan SS; Mittal P; Romero R
J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615
[TBL] [Abstract][Full Text] [Related]
15. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Sibai BM; Caritis SN; Thom E; Klebanoff M; McNellis D; Rocco L; Paul RH; Romero R; Witter F; Rosen M
N Engl J Med; 1993 Oct; 329(17):1213-8. PubMed ID: 8413387
[TBL] [Abstract][Full Text] [Related]
16. Maternal administration of the herbal medicine toki-shakuyaku-san promotes fetal growth and placental gene expression in normal mice.
Li H; Wada E; Wada K
Am J Chin Med; 2013; 41(3):515-29. PubMed ID: 23711139
[TBL] [Abstract][Full Text] [Related]
17. [Study on pharmacokinetics-pharmacodynamics correlation of Danshensu in rats with focal cerebral ischemia].
Ai JC; Zhou HF; Shu MC; Dai LL; Zheng L; Zhang YY; Yang JH; Wu XB; Wan HT
Zhongguo Zhong Yao Za Zhi; 2014 Jul; 39(14):2751-5. PubMed ID: 25272508
[TBL] [Abstract][Full Text] [Related]
18. Aspirin vs Heparin for the Prevention of Preeclampsia.
Katsi V; Kanellopoulou T; Makris T; Nihoyannopoulos P; Nomikou E; Tousoulis D
Curr Hypertens Rep; 2016 Jul; 18(7):57. PubMed ID: 27251704
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis.
Chen J; Huai J; Yang H
BMC Pregnancy Childbirth; 2024 Jan; 24(1):68. PubMed ID: 38233773
[TBL] [Abstract][Full Text] [Related]
20. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.
Downing JW; Ramasubramanian R; Johnson RF; Minzter BH; Paschall RL; Sundell HW; Engelhardt B; Lewis R
Med Hypotheses; 2004; 63(6):1057-64. PubMed ID: 15504576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
